Nitazoxanide Exerts Immunomodulatory Effects on Peripheral Blood Mononuclear Cells from Type 2 Diabetes Patients.
Mauricio Castillo-SalazarFausto Sánchez-MuñozRashidi Springall Del VillarGabriel Navarrete-VazquezAdrián Hernández-DiazCouderCarlos Mojica-CardosoSara García-JiménezCairo Toledano-JaimesGermán Bernal-FernándezPublished in: Biomolecules (2021)
Our results suggest that NTZ exerts immunomodulatory effects on PBMCs from T2D patients, and shows potential alternative therapeutic benefits.